-
2
-
-
0042337368
-
A mouse model of Rubinstein-Taybi syndrome: Defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4
-
Bourtchouladze R, Lidge R, Catapano R, Stanley J, Gossweiler S, Romashko D, Scott R, Tully T. 2003. A mouse model of Rubinstein-Taybi syndrome: Defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4. Proc Natl Acad Sci USA 100:10518-10522.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 10518-10522
-
-
Bourtchouladze, R.1
Lidge, R.2
Catapano, R.3
Stanley, J.4
Gossweiler, S.5
Romashko, D.6
Scott, R.7
Tully, T.8
-
3
-
-
37249038572
-
Status of the human malformation map
-
Part A in press
-
Carey JC, Viskochil DH. 2007. Status of the human malformation map: 2007. Am J Med Genet Part A (in press).
-
(2007)
Am J Med Genet
-
-
Carey, J.C.1
Viskochil, D.H.2
-
4
-
-
0030048999
-
Resynthesizing evolutionary and developmental biology
-
Gilbert SF, Opitz JM, Raff RA. 1996. Resynthesizing evolutionary and developmental biology. Dev Biol 173:357-372.
-
(1996)
Dev Biol
, vol.173
, pp. 357-372
-
-
Gilbert, S.F.1
Opitz, J.M.2
Raff, R.A.3
-
5
-
-
33645672459
-
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
-
Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. 2006. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117-121.
-
(2006)
Science
, vol.312
, pp. 117-121
-
-
Habashi, J.P.1
Judge, D.P.2
Holm, T.M.3
Cohn, R.D.4
Loeys, B.L.5
Cooper, T.K.6
Myers, L.7
Klein, E.C.8
Liu, G.9
Calvi, C.10
Podowski, M.11
Neptune, E.R.12
Halushka, M.K.13
Bedja, D.14
Gabrielson, K.15
Rifkin, D.B.16
Carta, L.17
Ramirez, F.18
Huso, D.L.19
Dietz, H.C.20
more..
-
6
-
-
0026771947
-
What did Gregor Mendel think he discovered?
-
Hart DL, Orel V. 1992. What did Gregor Mendel think he discovered? Genetics 131:245-253.
-
(1992)
Genetics
, vol.131
, pp. 245-253
-
-
Hart, D.L.1
Orel, V.2
-
7
-
-
34547433543
-
Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice
-
Hayashi ML, Rao BS, Seo JS, Choi HS, Dolan BM, Choi SY, Chattarji S, Tonegawa S. 2007. Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc Natl Acad Sci USA 104:11489-11494.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 11489-11494
-
-
Hayashi, M.L.1
Rao, B.S.2
Seo, J.S.3
Choi, H.S.4
Dolan, B.M.5
Choi, S.Y.6
Chattarji, S.7
Tonegawa, S.8
-
8
-
-
33748057833
-
-
Heller JH, Spiridigliozzi GA, Crissman BG, Sullivan-Saarela JA, Li JS, Kishnani PS. 2006. Clinical trials in children with Down syndrome: Issues from a cognitive research perspective. Am J Med Genet Part C Semin Med Genet 142C:187-195.
-
Heller JH, Spiridigliozzi GA, Crissman BG, Sullivan-Saarela JA, Li JS, Kishnani PS. 2006. Clinical trials in children with Down syndrome: Issues from a cognitive research perspective. Am J Med Genet Part C Semin Med Genet 142C:187-195.
-
-
-
-
11
-
-
33846033132
-
Recombinant human acid [alpha]-glucosidase: Major clinical benefits in infantile-onset Pompe disease
-
Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, Leslie N, Levine J, Spencer C, McDonald M, Li J, Dumontier J, Halberthal M, Chien YH, Hopkin R, Vijayaraghavan S, Gruskin D, Bartholomew D, van der Ploeg A, Clancy JP, Parini R, Morin G, Beck M, De la Gastine GS, Jokic M, Thurberg B, Richards S, Bali D, Davison M, Worden MA, Chen YT, Wraith JE. 2007. Recombinant human acid [alpha]-glucosidase: Major clinical benefits in infantile-onset Pompe disease. Neurology 68:99-109.
-
(2007)
Neurology
, vol.68
, pp. 99-109
-
-
Kishnani, P.S.1
Corzo, D.2
Nicolino, M.3
Byrne, B.4
Mandel, H.5
Hwu, W.L.6
Leslie, N.7
Levine, J.8
Spencer, C.9
McDonald, M.10
Li, J.11
Dumontier, J.12
Halberthal, M.13
Chien, Y.H.14
Hopkin, R.15
Vijayaraghavan, S.16
Gruskin, D.17
Bartholomew, D.18
van der Ploeg, A.19
Clancy, J.P.20
Parini, R.21
Morin, G.22
Beck, M.23
De la Gastine, G.S.24
Jokic, M.25
Thurberg, B.26
Richards, S.27
Bali, D.28
Davison, M.29
Worden, M.A.30
Chen, Y.T.31
Wraith, J.E.32
more..
-
12
-
-
27644517404
-
The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1
-
Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW, Cannon TD, Silva AJ. 2005. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 15:1961-1967.
-
(2005)
Curr Biol
, vol.15
, pp. 1961-1967
-
-
Li, W.1
Cui, Y.2
Kushner, S.A.3
Brown, R.A.4
Jentsch, J.D.5
Frankland, P.W.6
Cannon, T.D.7
Silva, A.J.8
-
13
-
-
36849068554
-
Versuche über Pflanzen-Hybriden-Verh naturforsch Ver Brunn
-
Mendel G. 1866. Versuche über Pflanzen-Hybriden-Verh naturforsch Ver Brunn. Transactions IV:3-47.
-
(1866)
Transactions IV:3-47
-
-
Mendel, G.1
-
15
-
-
36849008281
-
-
Opitz JM. 1989. Obituary: Charles W. Cotterman. Am J Med Genet 34:149-154.
-
Opitz JM. 1989. Obituary: Charles W. Cotterman. Am J Med Genet 34:149-154.
-
-
-
-
16
-
-
2142762493
-
The annals of morphology. Goethe's bone and the beginnings of morphology
-
Opitz JM. 2004. The annals of morphology. Goethe's bone and the beginnings of morphology. Am J Med Genet Part A 126A:1-8.
-
(2004)
Am J Med Genet
, vol.126 A
, Issue.PART A
, pp. 1-8
-
-
Opitz, J.M.1
-
17
-
-
36849082634
-
Wilhelm Weinberg - the centenary of the Hardy-Weinberg law
-
in preparation
-
Opitz JM. 2008. Wilhelm Weinberg - the centenary of the Hardy-Weinberg law. (in preparation).
-
(2008)
-
-
Opitz, J.M.1
-
18
-
-
30144431669
-
Annals of morphology: Meckel on developmental pathology
-
Opitz JM, Schultka R, Göbbel. 2006. Annals of morphology: Meckel on developmental pathology. Am J Med Genet Part A 140A:115-128.
-
(2006)
Am J Med Genet
, vol.140 A
, Issue.PART A
, pp. 115-128
-
-
Opitz, J.M.1
Schultka, R.2
Göbbel3
-
19
-
-
36849046392
-
-
Orel V. 1984. Mendel. Oxford University Press.
-
Orel V. 1984. Mendel. Oxford University Press.
-
-
-
-
20
-
-
28444444481
-
-
Rauch F, Glorieux FH. 2005. Osteogenesis imperfecta, current and future medical treatment. Am J Med Genet Part C Semin Med Genet 139C:31-37.
-
Rauch F, Glorieux FH. 2005. Osteogenesis imperfecta, current and future medical treatment. Am J Med Genet Part C Semin Med Genet 139C:31-37.
-
-
-
-
21
-
-
0033977311
-
Development: Mendel's legacy to genetics
-
Sandler I. 2000. Development: Mendel's legacy to genetics. Genetics 154:7-11.
-
(2000)
Genetics
, vol.154
, pp. 7-11
-
-
Sandler, I.1
-
22
-
-
33845971924
-
-
Superti-Furga A, Unger S. Nosology Group of the International Skeletal Dysplasia Society. 2007. Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet Part A 143A:1-18.
-
Superti-Furga A, Unger S. Nosology Group of the International Skeletal Dysplasia Society. 2007. Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet Part A 143A:1-18.
-
-
-
|